参考文献
[1]Oh J，Vidal-Jordana A，Montalban X.Multiple sclerosis:clinical aspects[J].Current Opinion in Neurology，2018，31（6）:752-759.
[2]邱伟，徐雁.多发性硬化诊断和治疗中国专家共识（2018版）[J].中国神经免疫学和神经病学杂志，2018，25（6）：387-394.
[3]全超，吴家勇，许勇峰，等.多发性硬化的规范化评估：泛长三角多发性硬化诊疗协作组专家建议（2023）[J].中国临床神经科学，2023，31（3）：241-251.
[4]Caparó-Zamalloa C，Velásquez-Rimachi V，Mori N，et al.Clinical pathway for the diagnosis and management of patients with relapsing-remitting multiple sclerosis:a first proposal for the peruvian population[J].Frontiers in Neurology，2021，12:667398.
[5]Hobart J，Bowen A，Pepper G，et al.International consensus on quality standards for brain health-focused care in multiple sclerosis[J].Multiple Sclerosis，2019，25（13）:1809-1818.
[6]Ghezzi A.European and American guidelines for multiple sclerosis treatment[J].Neurology and Therapy，2018，7（2）:189-194.
[7]Thompson AJ，Banwell BL，Barkhof F，et al.Diagnosis of multiple sclerosis:2017 revisions of the McDonald criteria[J].Lancet Neurology，2018，17（2）:162-173.
[8]Schwenkenbecher P，Wurster U，Konen FF，et al.Impact of the McDonald criteria 2017 on early diagnosis of relapsing-remitting multiple sclerosis[J].Frontiers in Neurology，2019，15（10）:188.
[9]Brownlee WJ，Hardy TA，Fazekas F，et al.Diagnosis of multiple sclerosis:progress and challenges[J].Lancet，2017，389（10076）:1336-1346.
[10]Mobasheri F，Jaberi AR，Hasanzadeh J，et al.Multiple sclerosis diagnosis delay and its associated factors among Iranian patients[J].Clinical Neurology and Neurosurgery，2020，199（1）:106278.
[11]Khedr EM，El Malky I，Hussein HB，et al.Multiple sclerosis diagnostic delay and its associated factors in Upper Egyptian patients[J].Scientific Reports，2023，13（1）:2249.
[12]Ghafari S，Fallahi-Khoshknab M，Norouzi K，et al.Experiences of hospitalization in patients with multiple sclerosis:A qualitative study[J].Iranian Journal of Nursing&Midwifery Research，2014，19（3）:255-261.
[13]Verónica Cabreira，Abreu P，Maia C，et al.Trends in hospital readmissions in multiple sclerosis patients between 2009 and 2015[J].Multiple Sclerosis and Related Disorders，2020，45:102396.
[14]Mendizabal A，Thibault DP，Crispo JA，et al.Comorbid disease drives short-term hospitalization outcomes in patients with multiple sclerosis[J].Neurology:Clinical Practice，2020，10（3）:255-264.
[15]Padarti A，Amritphale A，Kilgo W.Readmission rates in patients with multiple sclerosis:a nationwide cohort study[J].International Journal of MSCare，2022，24（5）:218-223.
[16]Scolding N，Barnes D，Cader S，et al.Association of British Neurologists:revised（2015）guidelines for prescribing disease-modifying treatments in multiple sclerosis.[J].Practical Neurology，2015，15（4）:273.(https://www.daowen.com)
[17]Khan F，Amatya B.Rehabilitation in multiple sclerosis:a systematic review of systematic reviews[J].Archives of Physical Medicine&Rehabilitation，2017，98（2）:353-367.
[18]Duan H，Jing Y，Li Y，et al.Rehabilitation treatment of multiple sclerosis[J].Frontiers in Immunology，2023，14:1168821.
[19]MS International Federation.MS Rehabilitation[EB/OL].（2021-10-26）[2023-08-11].https://www.msif.org/living-with-ms/rehabilitation/.
[20]Soler B，Raats J，Abasiyanik Z，et al.Systematic evaluation of the guidelines for rehabilitation in multiple sclerosis patients:an overview according to ICF functioning domains[J].International Journal of Rehabilitation Research，2021，44（4）:289-297.
[21]Thompson A，Kobelt G，Berg J，et al.New insights into the burden and costs of multiple sclerosis in Europe:results for the United Kingdom[J].Multiple Sclerosis，2017，23（2_suppl）:204-216.
[22]Rajachandrakumar R，Finlayson M.Multiple sclerosis caregiving:A systematic scoping review to map current state of knowledge[J].Health&social care in the community，2022，30（4）:e874-e897.
[23]Penchansky R，Thomas JW.The concept of access:definition and relationship to consumer satisfaction[J].Medical Care，1981，19（2）:127-140.
[24]Saurman，E.Improving access:modifying Penchansky and Thomas's Theory of Access[J].Journal of Health Services Research&Policy，2016，21（1）:36.
[25]Clement S，Brohan E，Jeffery D，et al.Development and psychometric properties the barriers to access to care evaluation scale（BACE）related to people with mental ill health[J].Bmc Psychiatry，2012，12（1）:36.
[26]Bauer MS，Williford WO，Mcbride L，et al.Perceived barriers to health care access in a treated population.[J].International Journal of Pharmaceutics，2005（1）:35.
【注释】
[1]应用于患者复发后或失去某种行为能力时。例如，当患者双腿力量减弱时，物理治疗可以通过抵抗性锻炼帮助改善力量和控制能力；痉挛和肌肉僵硬可以通过物理拉伸等来缓解。
[2]部分多发性硬化患者可能会出现言语和吞咽问题，治疗师会对其唇部、喉咙、舌头和喉部进行全面评估，以确定主要问题，进而采用策略纠正这些问题。
[3]侧重于培养和恢复与日常生活相关的技能，例如洗漱、穿衣、烹饪、行走、写作、上班或参与社交与休闲活动。
[4]提供服务、支持和培训，使多发性硬化患者能够得到工作机会、保持或提升工作能力。
[5]针对多发性硬化（MS）患者的心理咨询不仅仅是倾听和提供建议，还可以帮助应对MS带来的不确定性和不可预测性。